On 7 March 2025, the European Biosafety Network (EBN) participated in the Safer Cancer Care Conference in Brussels, joining a distinguished panel of speakers, healthcare professionals, researchers, and policymakers. The event centred on a critical goal: raising awareness… Read more
The EU Commission publishes a European List of Hazardous Medicinal Products, Based on ETUI Research
Hazardous medicinal products (HMPs)—including many anti-cancer agents, antivirals, and immunosuppressants—are integral to treating serious diseases but can also pose risks to healthcare professionals. These drugs can cause cancer or reproductive disorders in exposed workers, underlining the urgent need for… Read more
EBN Secretary Ian Lindsley presents at ‘The Future of Automated Compounding’ in Łódź, Poland
The Future of Automated Compounding was held in the Puro Hotel, Łódź on 8-9 June 2024, attended by pharmacists from all over Poland. Ian Lindsley’s presentation focused on the EBN white paper on ‘Preventing contamination, exposure and health… Read more
Millions of healthcare workers get protection from new EU law today
From today’s date, millions of workers (mostly women) in Europe will be protected for the first time by EU and national law from the impact of regular exposure in the workplace to potentially life-threatening hazardous drugs – hazardous medicinal… Read more
EBN to host Joint Summit on Preventing occupational exposure to Hazardous Medicinal Products
On Tuesday 30 January, 10am-3pm, Fórsa and the European Biosafety Network (EBN), in association with the Hospital Pharmacists Association of Ireland and the National Association of Hospital Pharmacy Technicians, are hosting a one-day Joint Summit in Dublin. The summit… Read more
Further protection for workers and healthcare professionals approved by European Parliament today
The Stop Cancer at Work coalition welcomes the overwhelming vote today in the Employment Committee of the European Parliament for better protection for workers and healthcare professionals from potentially life-threatening hazardous medicinal products (HMPs). The campaign urges the European… Read more
EBN Secretary Ian Lindsley presents at Hazardous Drugs Conference in London
The Hazardous Drugs: Best Practice for Nurses and Healthcare Institutions was held at the Wellcome Collection, London on April 21st 2023, attended by Clinical Governance Directors, Cancer Services Directors, Lead Cancer Nurses, Pharmacists and healthcare policy makers from across… Read more
EBN Presentation: Is your pharmacy ready for EU legislation?
Ian Lindsley, Secretary of the European Biosafety Network, gave a presentation to the conference of the International Society of Oncology Pharmacy Practitioners, ISOPP 2023, in Seville on 3 March entitled ‘Is your pharmacy ready for EU legislation?’ He… Read more
Protecting health workers from hazardous products
IAN LINDSLEY, TONY MUSU and ADAM ROGALEWSKI 9th February 2023 There is more clarity about hazardous medicinal products but awareness still needs to be raised to protect workers. Health workers need protection at all stages of the… Read more
Prevention of occupational cancers in the health sector, EBN with ETUI unveil list of HMPs
Two and a half years ahead of the European Commission, the ETUI with the EBN has unveiled a list of 121 hazardous medicinal products (HMPs) commonly used in the healthcare sector that can cause cancer or reproductive disorders in professionals… Read more
